Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 12/2012

01-12-2012 | Review Article

Prediction models for risk classification in cardiovascular disease

Authors: Mario Petretta, Alberto Cuocolo

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 12/2012

Login to get access

Abstract

Risk stratification is an increasingly important tool for the management of patients with different diseases and also for decision making in subjects not yet with overt disease but who are at risk of disease in the short or long term or during their lifetime. Careful risk assessment in the individual patient, based on clinical, laboratory and imaging data, can be helpful for making decisions about treatment or other prevention strategies. As regards cardiovascular disease, many models have been suggested and are available for the prediction of diagnosis and prognosis and there are several algorithms for risk prediction. However, current risk screening methods are not perfect. This review evaluates relative strengths and limitations of traditional and more recent methods for assessing the performance of prediction models.
Literature
1.
go back to reference Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.CrossRef Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.CrossRef
2.
go back to reference Sasieni PD, Shelton J, Ormiston-Smith N, Thomson CS, Silcocks PB. What is the lifetime risk of developing cancer?: the effect of adjusting for multiple primaries. Br J Cancer. 2011;105:460–5.PubMedCrossRef Sasieni PD, Shelton J, Ormiston-Smith N, Thomson CS, Silcocks PB. What is the lifetime risk of developing cancer?: the effect of adjusting for multiple primaries. Br J Cancer. 2011;105:460–5.PubMedCrossRef
4.
go back to reference Berry JD, Liu K, Folsom AR, Lewis CE, Carr JJ, Polak JF, et al. Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis. Circulation. 2009;119:382–9.PubMedCrossRef Berry JD, Liu K, Folsom AR, Lewis CE, Carr JJ, Polak JF, et al. Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis. Circulation. 2009;119:382–9.PubMedCrossRef
5.
go back to reference Persell SD, Zei C, Cameron KA, Zielinski M, Lloyd-Jones DM. Potential use of 10-year and lifetime coronary risk information for preventive cardiology prescribing decisions: a primary care physician survey. Arch Intern Med. 2010;170:470–7.PubMedCrossRef Persell SD, Zei C, Cameron KA, Zielinski M, Lloyd-Jones DM. Potential use of 10-year and lifetime coronary risk information for preventive cardiology prescribing decisions: a primary care physician survey. Arch Intern Med. 2010;170:470–7.PubMedCrossRef
6.
go back to reference Lloyd-Jones DM, Wilson PW, Larson MG, Beiser A, Leip EP, D’Agostino RB, et al. Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol. 2004;94:20–4.PubMedCrossRef Lloyd-Jones DM, Wilson PW, Larson MG, Beiser A, Leip EP, D’Agostino RB, et al. Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol. 2004;94:20–4.PubMedCrossRef
7.
go back to reference Farooq V, Brugaletta S, Vranckx P, Serruys PW. A guide to interpreting and assessing the performance of prediction models. EuroIntervention. 2011;6:909–12.PubMedCrossRef Farooq V, Brugaletta S, Vranckx P, Serruys PW. A guide to interpreting and assessing the performance of prediction models. EuroIntervention. 2011;6:909–12.PubMedCrossRef
8.
go back to reference Steyerberg EW, Pencina MJ, Lingsma HF, Kattan MW, Vickers AJ, Van Calster B. Assessing the incremental value of diagnostic and prognostic markers: a review and illustration. Eur J Clin Invest. 2012;42:216–28.PubMedCrossRef Steyerberg EW, Pencina MJ, Lingsma HF, Kattan MW, Vickers AJ, Van Calster B. Assessing the incremental value of diagnostic and prognostic markers: a review and illustration. Eur J Clin Invest. 2012;42:216–28.PubMedCrossRef
9.
10.
go back to reference Gerds TA, Cai T, Schumacher M. The performance of risk prediction models. Biom J. 2008;50:457–79.PubMedCrossRef Gerds TA, Cai T, Schumacher M. The performance of risk prediction models. Biom J. 2008;50:457–79.PubMedCrossRef
11.
go back to reference Lemeshow S, Hosmer Jr DW. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol. 1982;115:92–106.PubMed Lemeshow S, Hosmer Jr DW. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol. 1982;115:92–106.PubMed
12.
go back to reference Cook NR, Ridker PM. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med. 2009;150:795–802.PubMed Cook NR, Ridker PM. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med. 2009;150:795–802.PubMed
13.
go back to reference Pryor DB, Harrell Jr FE, Lee KL, Califf RM, Rosati RA. Estimating the likelihood of significant coronary artery disease. Am J Med. 1983;75:771–80.PubMedCrossRef Pryor DB, Harrell Jr FE, Lee KL, Califf RM, Rosati RA. Estimating the likelihood of significant coronary artery disease. Am J Med. 1983;75:771–80.PubMedCrossRef
14.
go back to reference Taylor AJ, Cerqueira M, Hodgson JM, Mark D, Min J, O’Gara P, et al. ACCF/SCCT/ACR/AHA/ASE/ASNC/ NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol. 2010;56:1864–94.PubMedCrossRef Taylor AJ, Cerqueira M, Hodgson JM, Mark D, Min J, O’Gara P, et al. ACCF/SCCT/ACR/AHA/ASE/ASNC/ NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol. 2010;56:1864–94.PubMedCrossRef
15.
go back to reference Morise AP, Haddad WJ, Beckner D. Development and validation of a clinical score to estimate the probability of coronary artery disease in men and women presenting with suspected coronary disease. Am J Med. 1997;102:350–6.PubMedCrossRef Morise AP, Haddad WJ, Beckner D. Development and validation of a clinical score to estimate the probability of coronary artery disease in men and women presenting with suspected coronary disease. Am J Med. 1997;102:350–6.PubMedCrossRef
16.
go back to reference Pryor DB, Shaw L, Harrell Jr FE, Lee KL, Hlatky MA, Mark DB, et al. Estimating the likelihood of severe coronary artery disease. Am J Med. 1991;90:553–62.PubMed Pryor DB, Shaw L, Harrell Jr FE, Lee KL, Hlatky MA, Mark DB, et al. Estimating the likelihood of severe coronary artery disease. Am J Med. 1991;90:553–62.PubMed
17.
go back to reference Do D, Marcus R, Froelicher V, Janosi A, West J, Atwood JE, et al. Predicting severe angiographic coronary artery disease using computerization of clinical and exercise test data. Chest. 1998;114:1437–45.PubMedCrossRef Do D, Marcus R, Froelicher V, Janosi A, West J, Atwood JE, et al. Predicting severe angiographic coronary artery disease using computerization of clinical and exercise test data. Chest. 1998;114:1437–45.PubMedCrossRef
18.
go back to reference Pencina MJ, D’Agostino RB, Larson MG, Massaro JM, Vasan RS. Predicting the 30-year risk of cardiovascular disease: the Framingham heart study. Circulation. 2009;119:3078–84.PubMedCrossRef Pencina MJ, D’Agostino RB, Larson MG, Massaro JM, Vasan RS. Predicting the 30-year risk of cardiovascular disease: the Framingham heart study. Circulation. 2009;119:3078–84.PubMedCrossRef
19.
go back to reference Steyerberg EW. Clinical prediction models: a practical approach to development, validation, and updating. New York: Springer; 2009. Steyerberg EW. Clinical prediction models: a practical approach to development, validation, and updating. New York: Springer; 2009.
20.
go back to reference Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes 3rd J. Factors of risk in the development of coronary heart disease – six year follow-up experience. The Framingham study. Ann Intern Med. 1961;55:33–50.PubMed Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes 3rd J. Factors of risk in the development of coronary heart disease – six year follow-up experience. The Framingham study. Ann Intern Med. 1961;55:33–50.PubMed
21.
go back to reference Sytkowski PA, Kannel WB, D’Agostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med. 1990;322:1635–41.PubMedCrossRef Sytkowski PA, Kannel WB, D’Agostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med. 1990;322:1635–41.PubMedCrossRef
22.
go back to reference Mozaffarian D, Wilson PW, Kannel WB. Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circulation. 2008;117:3031–8.PubMedCrossRef Mozaffarian D, Wilson PW, Kannel WB. Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circulation. 2008;117:3031–8.PubMedCrossRef
23.
go back to reference D’Agostino Sr RB, Grundy S, Sullivan LM, Wilson P; CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286:180–7.PubMedCrossRef D’Agostino Sr RB, Grundy S, Sullivan LM, Wilson P; CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286:180–7.PubMedCrossRef
24.
go back to reference Kannel WB, Neaton JD, Wentworth D, Thomas HE, Stamler J, Hulley SB, et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. Am Heart J. 1986;112:825–36.PubMedCrossRef Kannel WB, Neaton JD, Wentworth D, Thomas HE, Stamler J, Hulley SB, et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. Am Heart J. 1986;112:825–36.PubMedCrossRef
25.
go back to reference Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–47.PubMedCrossRef Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–47.PubMedCrossRef
26.
go back to reference D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation. 2008;117:743–53.PubMedCrossRef D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation. 2008;117:743–53.PubMedCrossRef
27.
go back to reference Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet. 1999;353:89–92.PubMedCrossRef Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet. 1999;353:89–92.PubMedCrossRef
28.
go back to reference Hense HW, Schulte H, Löwel H, Assmann G, Keil U. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany – results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J. 2003;24:937–45.PubMedCrossRef Hense HW, Schulte H, Löwel H, Assmann G, Keil U. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany – results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J. 2003;24:937–45.PubMedCrossRef
29.
go back to reference Empana JP, Tafflet M, Escolano S, Vergnaux AC, Bineau S, Ruidavets JB, et al. Predicting CHD risk in France: a pooled analysis of the D.E.S.I.R., Three City, PRIME, and SU.VI.MAX studies. Eur J Cardiovasc Prev Rehabil. 2011;18:175–85.PubMedCrossRef Empana JP, Tafflet M, Escolano S, Vergnaux AC, Bineau S, Ruidavets JB, et al. Predicting CHD risk in France: a pooled analysis of the D.E.S.I.R., Three City, PRIME, and SU.VI.MAX studies. Eur J Cardiovasc Prev Rehabil. 2011;18:175–85.PubMedCrossRef
30.
go back to reference Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation. 2002;105:310–5.PubMedCrossRef Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation. 2002;105:310–5.PubMedCrossRef
31.
go back to reference Assmann G, Schulte H, Seedorf U. Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study. Int J Obes (Lond). 2008;32 Suppl 2:S11–6.CrossRef Assmann G, Schulte H, Seedorf U. Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study. Int J Obes (Lond). 2008;32 Suppl 2:S11–6.CrossRef
32.
go back to reference Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, SCORE project group, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987–1003.PubMedCrossRef Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, SCORE project group, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987–1003.PubMedCrossRef
33.
go back to reference Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG). European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J. 2007;28:2375–414.PubMedCrossRef Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG). European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J. 2007;28:2375–414.PubMedCrossRef
34.
go back to reference Keil U, Fitzgerald AP, Gohlke H, Wellmann J, Hense HW. Risikostratifikation mit den neuen ESC-Risikotabellen für Deutschland. Dtsch Arztebl. 2005;102:A1808–12. Keil U, Fitzgerald AP, Gohlke H, Wellmann J, Hense HW. Risikostratifikation mit den neuen ESC-Risikotabellen für Deutschland. Dtsch Arztebl. 2005;102:A1808–12.
35.
go back to reference Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ. 2008;336:1475–82.PubMedCrossRef Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ. 2008;336:1475–82.PubMedCrossRef
36.
go back to reference Collins GS, Altman DG. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. Br Med J. 2010;340:c2442.CrossRef Collins GS, Altman DG. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. Br Med J. 2010;340:c2442.CrossRef
37.
go back to reference Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007;297:611–9.PubMedCrossRef Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007;297:611–9.PubMedCrossRef
38.
go back to reference Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation. 2008;118:2243–51.PubMedCrossRef Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation. 2008;118:2243–51.PubMedCrossRef
39.
go back to reference Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet. 2008;371:923–31.PubMedCrossRef Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet. 2008;371:923–31.PubMedCrossRef
40.
go back to reference Ferrario M, Chiodini P, Chambless LE, Cesana G, Vanuzzo D, Panico S; CUORE Project Research Group, et al. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol. 2005;34:413–21.PubMedCrossRef Ferrario M, Chiodini P, Chambless LE, Cesana G, Vanuzzo D, Panico S; CUORE Project Research Group, et al. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol. 2005;34:413–21.PubMedCrossRef
41.
go back to reference Hartz I, Njølstad I, Eggen AE. Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromsø study 2001. Eur Heart J. 2005;26:2673–80.PubMedCrossRef Hartz I, Njølstad I, Eggen AE. Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromsø study 2001. Eur Heart J. 2005;26:2673–80.PubMedCrossRef
42.
go back to reference Marques-Vidal P, Rodondi N, Bochud M, Pécoud A, Hayoz D, Paccaud F, et al. Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland. Eur J Cardiovasc Prev Rehabil. 2008;15:402–8.PubMedCrossRef Marques-Vidal P, Rodondi N, Bochud M, Pécoud A, Hayoz D, Paccaud F, et al. Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland. Eur J Cardiovasc Prev Rehabil. 2008;15:402–8.PubMedCrossRef
43.
go back to reference Woodward M, Brindle P, Tunstall-Pedoe H. SIGN group on risk estimation. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart. 2007;93:172–6.PubMedCrossRef Woodward M, Brindle P, Tunstall-Pedoe H. SIGN group on risk estimation. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart. 2007;93:172–6.PubMedCrossRef
44.
go back to reference Silber S, Jarre F, Pittrow D, Klotsche J, Pieper L, Zeiher AM, et al. DETECT-Studiengruppe. Cardiovascular risk assessment by primary-care physicians in Germany and its lack of agreement with the Established Risk Scores (DETECT). Med Klin (Munich). 2008;103:638–45.CrossRef Silber S, Jarre F, Pittrow D, Klotsche J, Pieper L, Zeiher AM, et al. DETECT-Studiengruppe. Cardiovascular risk assessment by primary-care physicians in Germany and its lack of agreement with the Established Risk Scores (DETECT). Med Klin (Munich). 2008;103:638–45.CrossRef
45.
go back to reference Sniderman AD, Furberg CD. Age as a modifiable risk factor for cardiovascular disease. Lancet. 2008;371:1547–9.PubMedCrossRef Sniderman AD, Furberg CD. Age as a modifiable risk factor for cardiovascular disease. Lancet. 2008;371:1547–9.PubMedCrossRef
46.
go back to reference Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, et al. Trends in serum lipids and lipoproteins of adults, 1960–2002. JAMA. 2005;294:1773–81.PubMedCrossRef Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, et al. Trends in serum lipids and lipoproteins of adults, 1960–2002. JAMA. 2005;294:1773–81.PubMedCrossRef
47.
go back to reference Cooney MT, Dudina A, D’Agostino R, Graham IM. Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future? Circulation. 2010;122:300–10.PubMedCrossRef Cooney MT, Dudina A, D’Agostino R, Graham IM. Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future? Circulation. 2010;122:300–10.PubMedCrossRef
48.
go back to reference Harrell Jr FE, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;247:2543–6.PubMedCrossRef Harrell Jr FE, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;247:2543–6.PubMedCrossRef
49.
go back to reference Gönen M, Heller G. Concordance probability and discriminatory power in proportional hazards regression. Biometrika. 2005;92:965–70.CrossRef Gönen M, Heller G. Concordance probability and discriminatory power in proportional hazards regression. Biometrika. 2005;92:965–70.CrossRef
50.
go back to reference Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56:337–44.PubMedCrossRef Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56:337–44.PubMedCrossRef
51.
go back to reference Antolini L, Boracchi P, Biganzoli E. A time-dependent discrimination index for survival data. Stat Med. 2005;24:3927–44.PubMedCrossRef Antolini L, Boracchi P, Biganzoli E. A time-dependent discrimination index for survival data. Stat Med. 2005;24:3927–44.PubMedCrossRef
52.
go back to reference Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115:928–35.PubMedCrossRef Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115:928–35.PubMedCrossRef
53.
go back to reference Janes H, Pepe MS, Gu W. Assessing the value of risk predictions using risk stratification tables. Ann Intern Med. 2008;149:751–60.PubMed Janes H, Pepe MS, Gu W. Assessing the value of risk predictions using risk stratification tables. Ann Intern Med. 2008;149:751–60.PubMed
54.
go back to reference Royston P, Sauerbrei W. A new measure of prognostic separation in survival data. Stat Med. 2004;23:723–48.PubMedCrossRef Royston P, Sauerbrei W. A new measure of prognostic separation in survival data. Stat Med. 2004;23:723–48.PubMedCrossRef
55.
go back to reference Pencina MJ, D’Agostino Sr RB, D’Agostino Jr RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–72.PubMedCrossRef Pencina MJ, D’Agostino Sr RB, D’Agostino Jr RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–72.PubMedCrossRef
56.
go back to reference Pencina MJ, D’Agostino Sr RB, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11–21.PubMedCrossRef Pencina MJ, D’Agostino Sr RB, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11–21.PubMedCrossRef
57.
go back to reference Cook NR, Paynter NP. Performance of reclassification statistics in comparing risk prediction models. Biom J. 2011;53:237–58.PubMedCrossRef Cook NR, Paynter NP. Performance of reclassification statistics in comparing risk prediction models. Biom J. 2011;53:237–58.PubMedCrossRef
58.
go back to reference Pencina MJ, D’Agostino Sr RB, D’Agostino Jr RB, Vasan RS. Comments on integrated discrimination and net reclassification improvements – practical advice. Stat Med. 2008;27:207–12.CrossRef Pencina MJ, D’Agostino Sr RB, D’Agostino Jr RB, Vasan RS. Comments on integrated discrimination and net reclassification improvements – practical advice. Stat Med. 2008;27:207–12.CrossRef
59.
go back to reference Cook NR. Comments on ‘Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond’ by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929). Stat Med 2008;27:191–5.PubMedCrossRef Cook NR. Comments on ‘Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond’ by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929). Stat Med 2008;27:191–5.PubMedCrossRef
60.
go back to reference Cook NR, Paynter NP. Genetics and breast cancer risk prediction – are we there yet? J Natl Cancer Inst. 2010;102:1605–6.PubMedCrossRef Cook NR, Paynter NP. Genetics and breast cancer risk prediction – are we there yet? J Natl Cancer Inst. 2010;102:1605–6.PubMedCrossRef
61.
go back to reference Janes H, Pepe MS. Matching in studies of classification accuracy: implications for analysis, efficiency, and assessment of incremental value. Biometrics. 2008;64:1–9.PubMedCrossRef Janes H, Pepe MS. Matching in studies of classification accuracy: implications for analysis, efficiency, and assessment of incremental value. Biometrics. 2008;64:1–9.PubMedCrossRef
62.
go back to reference Nelson CP, Lambert PC, Squire IB, Jones DR. Flexible parametric models for relative survival, with application in coronary heart disease. Stat Med. 2007;26:5486–98.PubMedCrossRef Nelson CP, Lambert PC, Squire IB, Jones DR. Flexible parametric models for relative survival, with application in coronary heart disease. Stat Med. 2007;26:5486–98.PubMedCrossRef
63.
go back to reference Vickers AJ, Cronin AM, Begg CB. One statistical test is sufficient for assessing new predictive markers. BMC Med Res Methodol. 2011;11:13.PubMedCrossRef Vickers AJ, Cronin AM, Begg CB. One statistical test is sufficient for assessing new predictive markers. BMC Med Res Methodol. 2011;11:13.PubMedCrossRef
64.
go back to reference Steyerberg EW, Van Calster B, Pencina MJ. Performance measures for prediction models and markers: evaluation of predictions and classifications. Rev Esp Cardiol. 2011;64:788–94.PubMedCrossRef Steyerberg EW, Van Calster B, Pencina MJ. Performance measures for prediction models and markers: evaluation of predictions and classifications. Rev Esp Cardiol. 2011;64:788–94.PubMedCrossRef
65.
66.
go back to reference Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26:565–74.PubMedCrossRef Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26:565–74.PubMedCrossRef
67.
go back to reference Rousson V, Zumbrunn T. Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studies. BMC Med Inform Decis Mak. 2011;11:45.PubMedCrossRef Rousson V, Zumbrunn T. Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studies. BMC Med Inform Decis Mak. 2011;11:45.PubMedCrossRef
68.
go back to reference Kallogjeri D, Piccirillo JF, Spitznagel Jr EL, Steyerberg EW. Comparison of scoring methods for ACE-27: simpler is better. Geriatr Oncol. 2012;3:238–45.CrossRef Kallogjeri D, Piccirillo JF, Spitznagel Jr EL, Steyerberg EW. Comparison of scoring methods for ACE-27: simpler is better. Geriatr Oncol. 2012;3:238–45.CrossRef
69.
go back to reference Shaw LJ. The new era of risk reclassification in cardiovascular imaging. J Nucl Cardiol. 2011;18:536–7.PubMedCrossRef Shaw LJ. The new era of risk reclassification in cardiovascular imaging. J Nucl Cardiol. 2011;18:536–7.PubMedCrossRef
70.
go back to reference Shaw LJ, Wilson PW, Hachamovitch R, Hendel RC, Borges-Neto S, Berman DS. Improved near-term coronary artery disease risk classification with gated stress myocardial perfusion SPECT. JACC Cardiovasc Imaging. 2010;3:1139–48.PubMedCrossRef Shaw LJ, Wilson PW, Hachamovitch R, Hendel RC, Borges-Neto S, Berman DS. Improved near-term coronary artery disease risk classification with gated stress myocardial perfusion SPECT. JACC Cardiovasc Imaging. 2010;3:1139–48.PubMedCrossRef
71.
go back to reference Acampa W, Petretta M, Evangelista L, Daniele S, Xhoxhi E, De Rimini ML, et al. The IDIS study: a prospective, multicentre trial. Myocardial perfusion imaging and risk classification for coronary heart disease in diabetic patients. Eur J Nucl Med Mol Imaging. 2012;39:387–95.PubMedCrossRef Acampa W, Petretta M, Evangelista L, Daniele S, Xhoxhi E, De Rimini ML, et al. The IDIS study: a prospective, multicentre trial. Myocardial perfusion imaging and risk classification for coronary heart disease in diabetic patients. Eur J Nucl Med Mol Imaging. 2012;39:387–95.PubMedCrossRef
Metadata
Title
Prediction models for risk classification in cardiovascular disease
Authors
Mario Petretta
Alberto Cuocolo
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 12/2012
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-012-2254-1

Other articles of this Issue 12/2012

European Journal of Nuclear Medicine and Molecular Imaging 12/2012 Go to the issue